Xponance Inc. Buys 23,807 Shares of Colgate-Palmolive Company $CL

Xponance Inc. lifted its position in Colgate-Palmolive Company (NYSE:CL) by 14.9% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 183,599 shares of the company’s stock after purchasing an additional 23,807 shares during the period. Xponance Inc.’s holdings in Colgate-Palmolive were worth $14,677,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC raised its holdings in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after acquiring an additional 450 shares in the last quarter. Woodline Partners LP raised its holdings in shares of Colgate-Palmolive by 76.3% in the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after purchasing an additional 20,062 shares in the last quarter. Schnieders Capital Management LLC. lifted its position in shares of Colgate-Palmolive by 2.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock worth $1,136,000 after purchasing an additional 245 shares during the period. Envestnet Asset Management Inc. boosted its stake in shares of Colgate-Palmolive by 0.4% during the second quarter. Envestnet Asset Management Inc. now owns 678,352 shares of the company’s stock valued at $61,662,000 after purchasing an additional 2,768 shares in the last quarter. Finally, Bessemer Group Inc. increased its holdings in Colgate-Palmolive by 16.0% during the second quarter. Bessemer Group Inc. now owns 19,264 shares of the company’s stock valued at $1,751,000 after buying an additional 2,650 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CL has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft increased their target price on Colgate-Palmolive from $83.00 to $90.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. TD Cowen reiterated a “buy” rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. Morgan Stanley increased their price target on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a research report on Tuesday, December 9th. Finally, Barclays boosted their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 3rd. Eleven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $94.75.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 97,843 shares of the firm’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the completion of the transaction, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. This trade represents a 63.89% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider John Hazlin sold 20,989 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the sale, the insider owned 17,645 shares of the company’s stock, valued at approximately $1,663,041.25. The trade was a 54.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 184,683 shares of company stock worth $17,486,693. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Trading Up 1.5%

Shares of Colgate-Palmolive stock opened at $99.01 on Friday. The firm’s 50 day simple moving average is $87.49 and its two-hundred day simple moving average is $82.73. The firm has a market capitalization of $79.81 billion, a price-to-earnings ratio of 37.79, a PEG ratio of 4.40 and a beta of 0.29. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $100.18. The company has a current ratio of 0.83, a quick ratio of 0.27 and a debt-to-equity ratio of 18.82.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.91 earnings per share. Analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.1%. The ex-dividend date was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 79.39%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.